Literature DB >> 23269856

Ruthenium-Catalyzed Olefin Metathesis after Tetra-n-butylammonium Fluoride-Mediated Desilylation.

Sami Osman1, Kazunori Koide.   

Abstract

One-pot procedures expedite organic synthesis but pose challenges in that many reagents must be compatible with each other. We discovered that the presence of (n)Bu(4)NF hindered rutheniumcatalyzed olefin metathesis when (n)Bu(4)NF-mediated desilylation and olefin metathesis were performed in one pot. This problem could be solved by the addition of (TMS)(2)O to remove fluoride anions in order to facilitate the ruthenium-catalyzed olefin metathesis.

Entities:  

Year:  2012        PMID: 23269856      PMCID: PMC3529171          DOI: 10.1016/j.tetlet.2012.09.035

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  25 in total

1.  Identification of SAP155 as the target of GEX1A (Herboxidiene), an antitumor natural product.

Authors:  Makoto Hasegawa; Tatsuhiro Miura; Kouji Kuzuya; Ayu Inoue; Se Won Ki; Sueharu Horinouchi; Tetsuo Yoshida; Tatsuki Kunoh; Koichi Koseki; Koshiki Mino; Ryuzo Sasaki; Minoru Yoshida; Tamio Mizukami
Journal:  ACS Chem Biol       Date:  2011-01-13       Impact factor: 5.100

2.  New antitumor substances, FR901463, FR901464 and FR901465. III. Structures of FR901463, FR901464 and FR901465.

Authors:  H Nakajima; S Takase; H Terano; H Tanaka
Journal:  J Antibiot (Tokyo)       Date:  1997-01       Impact factor: 2.649

3.  New antitumor substances, FR901463, FR901464 and FR901465. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities.

Authors:  H Nakajima; B Sato; T Fujita; S Takase; H Terano; M Okuhara
Journal:  J Antibiot (Tokyo)       Date:  1996-12       Impact factor: 2.649

4.  Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A.

Authors:  Anna Corrionero; Belén Miñana; Juan Valcárcel
Journal:  Genes Dev       Date:  2011-03-01       Impact factor: 11.361

5.  Quantitative structure-activity relationships of ruthenium catalysts for olefin metathesis.

Authors:  Giovanni Occhipinti; Hans-René Bjørsvik; Vidar R Jensen
Journal:  J Am Chem Soc       Date:  2006-05-31       Impact factor: 15.419

6.  Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. I. Taxonomy, fermentation, isolation and screening.

Authors:  Takashi Sakai; Tomohiro Sameshima; Motoko Matsufuji; Naoto Kawamura; Kazuyuki Dobashi; Yoshiharu Mizui
Journal:  J Antibiot (Tokyo)       Date:  2004-03       Impact factor: 2.649

7.  Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. III. In vitro and in vivo antitumor activities.

Authors:  Yoshiharu Mizui; Takashi Sakai; Masao Iwata; Toshimitsu Uenaka; Kiyoshi Okamoto; Hajime Shimizu; Takao Yamori; Kentaro Yoshimatsu; Makoto Asada
Journal:  J Antibiot (Tokyo)       Date:  2004-03       Impact factor: 2.649

8.  Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. II. Physico-chemical properties and structure elucidation.

Authors:  Takashi Sakai; Naoki Asai; Akifumi Okuda; Naoto Kawamura; Yoshiharu Mizui
Journal:  J Antibiot (Tokyo)       Date:  2004-03       Impact factor: 2.649

9.  Splicing factor SF3b as a target of the antitumor natural product pladienolide.

Authors:  Yoshihiko Kotake; Koji Sagane; Takashi Owa; Yuko Mimori-Kiyosue; Hajime Shimizu; Mai Uesugi; Yasushi Ishihama; Masao Iwata; Yoshiharu Mizui
Journal:  Nat Chem Biol       Date:  2007-07-22       Impact factor: 15.040

10.  Early transition-metal perfluoroalkyl complexes.

Authors:  Felicia L Taw; Brian L Scott; Jaqueline L Kiplinger
Journal:  J Am Chem Soc       Date:  2003-12-03       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.